UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in INVA — Innoviva, Inc.
CIK 861177
NEW YORK, NY
Position in INVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,135,503
+$657,645 QoQ
Shares Held
134,571
+8.6% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 61.58161862511239.ToString("F0")%
Shared 0.ToString("F0")%
None 38.41838137488761.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. INVA ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,135,503 | 134,571 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,477,858 | 123,955 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,975,926 | 108,270 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,269,203 | 212,504 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,102,331 | 171,116 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,434,621 | 140,324 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,538,279 | 131,449 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,532,321 | 154,410 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $686,468 | 45,044 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $722,696 | 45,056 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $904,855 | 69,658 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $950,674 | 74,680 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $840,149 | 74,680 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $861,116 | 64,990 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $661,385 | 56,967 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $998,364 | 67,640 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,167,925 | 60,358 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,041,174 | 60,358 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $779,770 | 46,665 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $598,299 | 44,616 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $622,439 | 52,087 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,115,371 | 90,022 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $940,728 | 90,022 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $920,834 | 65,868 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $941,469 | 80,057 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||